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Abstract
Background: Myocardial T1-mapping recently emerged as a promising quantitative method for non-invasive tissue
characterization in numerous cardiomyopathies. Commonly performed with an inversion-recovery (IR) magnetization
preparation at 1.5T, the application at 3T has gained due to increased quantification precision. Alternatively,
saturation-recovery (SR) T1-mapping has recently been introduced at 1.5T for improved accuracy.
Thus, the purpose of this study is to investigate the robustness and precision of SR T1-mapping at 3T and to establish
accurate reference values for native T1-times and extracellular volume fraction (ECV) of healthy myocardium.
Methods: Balanced Steady-State Free-Precession (bSSFP) Saturation-Pulse Prepared Heart-rate independent
Inversion-REcovery (SAPPHIRE) and Saturation-recovery Single-SHot Acquisition (SASHA) T1-mapping were
compared with the Modified Look-Locker inversion recovery (MOLLI) sequence at 3T. Accuracy and precision
were studied in phantom. Native and post-contrast T1-times and regional ECV were determined in 20 healthy
subjects (10 men, 27 ± 5 years). Subjective image quality, susceptibility artifact rating, in-vivo precision and
reproducibility were analyzed.
Results: SR T1-mapping showed <4 % deviation from the spin-echo reference in phantom in the range of
T1 = 100–2300 ms. The average quality and artifact scores of the T1-mapping methods were: MOLLI:3.4/3.6,
SAPPHIRE:3.1/3.4, SASHA:2.9/3.2; (1: poor - 4: excellent/1: strong - 4: none). SAPPHIRE and SASHA yielded
significantly higher T1-times (SAPPHIRE: 1578 ± 42 ms, SASHA: 1523 ± 46 ms), in-vivo T1-time variation
(SAPPHIRE: 60.1 ± 8.7 ms, SASHA: 70.0 ± 9.3 ms) and lower ECV-values (SAPPHIRE: 0.20 ± 0.02, SASHA: 0.21 ± 0.03)
compared with MOLLI (T1: 1181 ± 47 ms, ECV: 0.26 ± 0.03, Precision: 53.7 ± 8.1 ms). No significant difference was found
in the inter-subject variability of T1-times or ECV-values (T1: p = 0.90, ECV: p = 0.78), the observer agreement
(inter: p > 0.19; intra: p > 0.09) or consistency (inter: p > 0.07; intra: p > 0.17) between the three methods.
Conclusions: Saturation-recovery T1-mapping at 3T yields higher accuracy, comparable inter-subject, inter- and
intra-observer variability and less than 30 % precision-loss compared to MOLLI.
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Background
The recent introduction of rapid parameter mapping
into cardiovascular magnetic resonance (CMR) imaging
provides the invaluable ability for noninvasive quantita-
tive myocardial tissue characterization. The quantifica-
tion of the native longitudinal magnetization recovery
time as a spatially resolved map (native T1-mapping)
shows promising prognostic and diagnostic value in
various cardiomyopathies [1]. The combination with
post-contrast T1-time measurements allows for the esti-
mation of the extracellular volume fraction (ECV),
which reflects fibrotic remodeling [2], a common end-
point of many pathological cardiac conditions [3].
A number of cardiac T1-mapping methods have been
proposed, each offering a distinct profile of advantages.
The modified Look-Locker inversion recovery (MOLLI)
sequence [4] and variations thereof, like the shortened
MOLLI (ShMOLLI) [5], are commonly used for myocar-
dial T1-mapping. However, confounding factors to the
method’s quantification accuracy including heart rate
[6], T2 relaxation time [7], and magnetization transfer
[8] lead to underestimation of the T1-time of the healthy
myocardium by ~20 % at 1.5T [9, 10].
Alternatively, saturation-recovery (SR) based myocar-
dial T1-mapping methods have been proposed [11] and
were recently revisited by the SAturation-recovery
single-SHot Acquisition (SASHA) sequence [12]. To in-
crease the low dynamic range in SR T1-mapping, the hy-
brid sequence for Saturation Pulse Prepared Heart-rate
independent Inversion-REcovery (SAPPHIRE) T1-map-
ping was introduced, using a combination of saturation
and inversion pulses for magnetization preparation [6].
While SASHA and SAPPHIRE result in excellent accur-
acy, the sequences still suffer from reduced precision in
assessing T1-times compared with MOLLI, as previously
shown at 1.5T [9].
The application of inversion-recovery T1-mapping at
3T has recently received increasing interest. Multiple
studies have shown promising T1-map quality and
improved quantification precision, due to the increased
imaging Signal-to-Noise ratio (SNR) at 3T [5, 13, 14].
Thus, in this work we sought to study the visual quality
and precision of SR T1-mapping and to establish accur-
ate reference values for native T1-times and ECV-values
of the healthy myocardium at 3T.
Methods
All images were acquired on a 3T MRI scanner (Magnetom
Skyra; Siemens Healthcare, Erlangen, Germany) with a
30-channel receiver coil array.
Sequences
T1-mapping was performed using the SAPPHIRE and
SASHA SR methods and T1-times were compared to
MOLLI T1-mapping. All T1-mapping sequences were im-
plemented with a balanced Steady-State Free-Precession
image acquisition (bSSFP) and shared the following
parameters for phantom and in-vivo imaging: TR/TE/α =
2.6 ms/1.0 ms/35°, in-plane resolution = 1.7 × 1.7 mm2,
slice-thickness = 6 mm, field-of-view = 440 × 375 mm2,
bandwidth = 1085Hz/px, number of k-space lines = 139,
linear profile ordering, startup-pulses = 5 Kaiser-Bessel,
GRAPPA-factor = 2. The 5(3)3 MOLLI scheme was
employed for native T1-mapping and the 4(1)3(1)2 scheme
for post-contrast imaging [15]. For SAPPHIRE and
SASHA, 10 images were acquired with the 9 recovery
times (inversion or saturation times, respectively) linearly
spaced between the minimal (113 ms) and the maximum
recovery time, as determined by the duration of the
respective R-R interval. Magnetization saturation was
achieved using a composite “Water suppression Enhanced
through T1-effects” (WET) [16] saturation module. An
adiabatic full passage tan/tanh pulse [17] was used for
magnetization inversion.
Phantom experiments
Phantom scans were performed to study pulse-efficacy,
ex-vivo accuracy and precision of the SR T1-mapping
methods at 3T. Detailed description of the phantom
experiments can be found in the Additional file 1.
In-vivo experiments
20 healthy volunteers (27 ± 5 years, ranging from 20 to
39 years; 10 male: 27 ± 6 years; 10 female: 27 ± 4 years)
were recruited for native and post-contrast T1-mapping.
Figure 1 depicts the schematic of the scan protocol: A
blood sample was drawn prior to each examination to
measure blood hematocrit for ECV calculation and to
exclude impaired renal function before the administra-
tion of a gadolinium based contrast agent (GBCA).
Imaging was performed before bolus administration of
0.2 mmol/kg gadoterate meglumine (Dotarem; Guerbet,
Aulnay-sous-Bois, France), and 15 and 25 min there-
after. T1-maps were acquired in three short-axis slices.
Based on bSSFP frequency scout images, frequency
offsets in the range of ±50 Hz and ±100 Hz were
selected for MOLLI and the SR methods, respectively.
Different off-resonance frequency shifts were chosen for
MOLLI and SR, due to previously reported off-resonance
sensitivity for the MOLLI sequence and off-resonance
resilience for SR methods [10]. Post-contrast scan order
was randomized to mitigate T1-trends caused by GBCA
washout (Fig. 1).
Post-processing
Motion correction (MoCo, Advanced Retrospective
Technique; Siemens Healthcare, Erlangen, Germany)
was applied to co-register the T1-weighted image series.
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T1-maps were generated a) from the MoCo image series
when the registration algorithm reduced residual motion
and b) from the uncorrected image series when MoCo
introduced registration distortions, as judged by visual
assessment in consensus agreement of two reviewers
(SW; 6 years of CMR experience, NMM; 4 years of
CMR experience).
MOLLI T1-times were obtained using standard post-
processing [4] and SR T1-maps were generated using a
three-parameter fit [18]. Regional ECV-values were
calculated segment-wise according to the AHA 16-
segment model [19] for both post-contrast time points.
Contrast agent concentrations were calculated for the
myocardium and the blood-pool, based on the difference
in the native and post-contrast relaxation rates (1/T1) di-
vided by an assumed relaxivity of 3.5 mmol/L/s [20].
T1-map analysis
Quantitative evaluation of T1-times and ECV-values was
performed on a per-segment basis. In-vivo precision was
defined as the intra-segment variation, measured in terms
of standard deviation. Visual T1-map quality was evalu-
ated by two readers, which were blinded to the sequence
type (JB; >5 years of CMR experience; DL; >11 years of
CMR experience). Each slice was scored separately with
respect to overall T1-map quality (1: poor – 4: excellent)
[15] and visual off-resonance artifacts in the T1-map
(1: strong artifacts – 4: none). The detailed scoring
criteria can be found in Additional file 2.
Average T1-times and ECV-values were statistically
compared on a per-subject basis among the methods
using ANOVA, followed by pair-wise paired Student’s
t-tests, if significant differences among the methods were
detected. The inter-subject variability of the T1-times
and ECV-values was compared among the methods
using a Bartlett-test, and paired F-tests in case of signifi-
cant results of the former. ECV-values between the two
post-contrast time points were compared using a paired
Student’s t-test for each method. Furthermore, inter-
and intra-observer variability was studied for native and
post-contrast T1- mapping with the three sequences. A
total of three ROI sets was independently drawn by two
readers for each sequence and time point (Reader 1:
UM, 12 years of CMR experience, Reader 2: NMM,
4 years of CMR experience; Reader 1: ROIs A, Reader 2:
ROIs B, ROIs C). T1-times obtained with different ROI
sets were compared on a per subject-basis for inter-
(ROIs A vs. ROIs B) and intra-observer (ROIs B vs. ROIs
C) analysis. Observer agreement was studied by analyz-
ing the absolute difference between the T1-times as
proposed in [21]. Observer consistency was assessed
using the intraclass correlation coefficient (ICC) based
on Winer’s adjustment for anchor points [22]. The
T1-time variation and the ordinal scaled image ratings
were statistically evaluated using Kruskal-Wallis tests with
subsequent Mann–Whitney U tests in case of significant
difference between the three methods. Differences in the
observer agreement were assessed with one-way analysis
of variance (ANOVA) of the log-transformed absolute
difference [22]. ICCs were statistically compared using
two-tailed F-statistics, with Bonferroni correction yielding
significance for p < 0.017. All other statistical tests were
performed at a significance level of p < 0.05.
Results
Phantom experiments
WET saturation modules resulted in average saturation
efficacy >99 % across a broad T1-range. The SR methods
showed excellent accuracy (<3.9 % deviation). T1-time
variation was 29 and 50 % lower using MOLLI com-
pared with SAPPHIRE and SASHA, respectively.
In-vivo experiments
Scanning was successfully completed in all subjects, with
no pathological findings. Eight (0.09 %) out of a total of
8640 segments were excluded from further analysis due
to imaging artifacts (SAPPHIRE: 4, 0.14 %; SASHA: 4,
0.14 %). Post-contrast results are given for the first time
point (~15 min) in the remainder of the study if not
explicitly stated otherwise.
Fig. 1 In-vivo imaging protocol: After blood draw, all subjects underwent MR examination of approximately 1 h duration, including T1-mapping
sessions prior to, 15 and 25 min after GBCA injection. Basic adjustments and frequency scouting were performed before native T1-mapping. To
minimize the effects of GBCA washout on inter-sequence comparison, measurements of the same slices were grouped. The sequence orders
within the group, as well as the slice order were randomized for each subject
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Figure 2 shows exemplary native and post-contrast T1-
maps acquired with MOLLI, SAPPHIRE and SASHA in
two healthy subjects. All three methods depict a homo-
geneous myocardium clear of artifacts.
Native T1-time, T1-time precision and ECV-values are
presented for the 16 AHA segments as bullseye plots in
Fig. 3. MOLLI T1-times (1181 ± 47 ms) show a 20–29 %
underestimation compared with SR T1-times (SAPPHIRE:
1578 ± 42 ms, p < 0.001; SASHA: 1523 ± 46 ms, p < 0.001).
SAPPHIRE T1-times were slightly higher than SASHA
T1-times (difference: 3.5 ± 1.9 %, p < 0.001). No significant
difference was found between the inter-subject variabilities
of the three methods (MOLLI: 47 ms, SAPPHIRE: 42 ms,
SASHA: 46 ms, p = 0.90).
The MOLLI in-vivo variation (53.7 ± 8.1 ms) shows no
significant difference (p = 0.057) compared with SAPPHIRE
(60.1 ± 8.7 ms), but a significant reduction compared with
SASHA (70.0 ± 9.3 ms, p < <0.001). SAPPHIRE yields lower
variation than SASHA (14 ± 10 %, p < 0.002). Both SR T1-
mapping methods show a trend of increased variation in
the inferior, inferior-lateral and anterior segments, com-
pared with the septal and anterior-lateral segments.
Figure 3 (bottom row) shows the segmental ECV based
on the first post-contrast session. MOLLI yields the lowest
ECV-values, followed by SAPPHIRE and SASHA, with all
differences being significant (p < 0.007). There was no sig-
nificant difference between the inter-subject variability of
the ECV-values obtained with MOLLI (0.026), SAPPHIRE
(0.020) and SASHA (0.025) (p = 0.53).
A summary of T1-times and ECV-values for the native
myocardium and both post-contrast times are given in
Table 1. The second post-contrast imaging time showed
a trend of higher ECV-values than the first time point,
with an absolute deviation of 0.014 ± 0.016 for MOLLI
(p < 0.001), 0.008 ± 0.013 for SAPPHIRE (p < 0.02), and
0.005 ± 0.020 for SASHA (p = 0.24).
The results from the inter- and intra-observer analysis
are given in Table 2. High reproducibility in terms of
agreement was shown for all three sequences, with mean
differences <15 ms for native and <6 ms for post-contrast
T1-mapping. Good intra-observer consistency was ob-
tained in all scans (ICC > 0.97). Inter-observer consistency
was slightly lower across the three sequences, especially
for native T1-times (ICC > 0.94). No statistically significant
difference was found among the three sequences, neither
in terms of agreement nor consistency.
Figure 4 depicts the readers’ quality and artifact scores.
All three sequences were scored with “good” image qual-
ity on the average. MOLLI resulted in the highest aver-
age quality scores, followed by SAPPHIRE. The SASHA
method showed the lowest quality in visual assessment.
All pair-wise differences were found to be significant
(p < 0.03). The average artifact scoring was signifi-
cantly better for MOLLI (3.6 ± 0.3) compared with
SAPPHIRE (3.4 ± 0.3, p = 0.03) and SASHA (3.2 ± 0.3,
p = 0.001). Example images illustrating the effect of
off-resonance artifacts on the T1-maps are given in
Additional file 3: Figure S3.
MoCo was successfully performed on almost all
MOLLI imaging series (97 %) and on the majority of
the SAPPHIRE data (82 %). However, only few
SASHA imaging series were correctly registered using
MoCo (8 %).
Discussion
In this study, we assessed reference values and in-vivo
precision of SR T1-mapping at 3T in comparison with
MOLLI. SR T1-mapping provided robust image quality
throughout the study. MOLLI T1-maps were shown to
consistently provide the highest image quality rating and
lowest artifact incidence. However, significantly better
ex-vivo accuracy was confirmed for SR methods for the
trade-off against a slight reduction of in-vivo precision.
No significant difference was found in the inter-subject
variability and the inter-and intra-observer variability
among the three methods.
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Fig. 2 Example T1-maps acquired prior to and 25 min after GBCA
injection with all three T1-mapping sequences in short axis
mid-ventricular slices of two healthy subjects. Visually high T1-map
quality is apparent, with no artifacts and homogenous T1-times
throughout the myocardium with all three methods. Sharp
delineation of the myocardium against the blood-pools is observed for
both native T1 and T1 post-contrast. MOLLI T1-maps show systematically
lower T1-times compared with the saturation-recovery sequences
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Fig. 3 Bullseye plots comparing the native T1-times (top row), precision (middle row) and the ECV-values (bottom row) of the three T1-mapping
sequences averaged over all volunteers. The given ECV-values were calculated from post-contrast T1 acquired 15 min after GBCA injection.
Segmentation was performed according to the AHA 16-segment model in three short-axis slices (A = apical, M =mid-ventricular, B = basal). The
average across all segments is given in the center of the bullseye, the slice averages can be found below. The MOLLI sequence shows lower T1,
better precision and higher ECV-values compared to the saturation-recovery methods. SAPPHIRE results show similar native T1- and ECV-values
with slightly better precision compared with SASHA
Table 1 Myocardial and blood T1-times measured with MOLLI and two saturation-recovery techniques at 3T
MOLLI SAPPHIRE SASHA
Native T1-time [ms] Myo 1182.6 ± 35.8 1578.1 ± 35.9 1522.8 ± 40.5
Blood 1781.4 ± 135.7 2047.6 ± 132.0 1919.3 ± 134.2
Post 1 (~15 min) T1-time [ms] Myo 541.1 ± 33.8 746.2 ± 49.3 722.0 ± 57.2
Blood 349.1 ± 34.4 387.4 ± 37.4 390.6 ± 42.6
ECV [%] 26.0 ± 2.6 20.2 ± 2.0 21.3 ± 2.5
GBCA Concentration [μmol/L] Myo 288.5 ± 38.5 203.2 ± 27.9 210.2 ± 34.7
Blood 665.4 ± 85.7 604.2 ± 72.6 590.4 ± 84.1
Post 2 (~25 min) T1-time [ms] Myo 581.5 ± 33.0 794.1 ± 46.9 773.2 ± 55.6
Blood 405.6 ± 39.5 439.3 ± 39.8 441.7 ± 43.8
ECV [%] 27.5 ± 3.1 21.0 ± 2.8 21.9 ± 3.0
GBCA Concentration [μmol/L] Myo 251.4 ± 38.5 179.7 ± 24.3 183.5 ± 31.0
Blood 550.3 ± 75.5 515.9 ± 62.7 504.2 ± 72.4
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Native T1-times of the human myocardium using SR
T1-mapping were found to be around 1550 ms. This re-
veals a field strength dispersion of approximately 30 %
compared with 1.5T (1210–1220 ms [9]), which is in
good agreement with reported literature values for
cardiac tissue of animals [23, 24]. MOLLI T1-times from
our own findings and previous reports at 3T (1166 ms
[14]) demonstrate a significant underestimation of about
20–30 % compared with the present results of SR T1-
mapping. This underestimation, as confirmed by the
phantom study, indicates decreased in-vivo accuracy of
MOLLI. SASHA T1-mapping was previously reported to
have about 150 % higher in-vivo variability than MOLLI
at 1.5T [10]. Our results demonstrate that the loss in
precision when using SR over MOLLI is drastically
reduced compared with 1.5T. The present results indi-
cate that at 3T, MOLLI remains to provide higher visual
image quality than SR methods. However, the high ex-
vivo accuracy, the low level of precision-loss, and the
good inter-subject variability, indicate only a small gap
to SR T1-mapping. Hence, SR methods at 3T provide a
valuable option for trading-off increased quantification
accuracy against a reduction of overall image-quality.
Alternative T1-map reconstructions have been pro-
posed for SR T1-mapping, to improve precision albeit at
the cost of reduced accuracy and increased sensitivity of
Table 2 Inter- and Intra-observer variability. The upper part of the table lists the results from the agreement analysis, based on absolute
differences between the ROI sets. The lower part of the table depicts the consistency analysis, based on an ICC (Winer’s adjustment for
anchor points). No significant difference was found among the sequences
Geometric Mean of Absolute Difference [CI = 95 %] p-value*
MOLLI SAPPHIRE SASHA
Inter Native 11.3 [3.7–30.5] 13.0 [5.7–30.4] 8.8 [1.6–27.0] 0.27
Post 2.8 [0.2–22.8] 5.3 [0.7–23.2] 5.3 [0.6–20.1] 0.19
Intra Native 7.1 [1.2–18.7] 5.1 [0.7–16.4] 3.3 [0.3–13.3] 0.09
Post 3.6 [1.2–13.5] 4.1 [0.5–18.8] 3.2 [0.5–17.1] 0.69
ICC [CI = 95 %] p-value**
MOLLI SAPPHIRE SASHA
Inter Native 0.941 [0.858–0.976] 0.973 [0.932–0.989] 0.958 [0.898–0.983] >0.10
Post 0.983 [0.957–0.993] 0.968 [0.920–0.987] 0.986 [0.965–0.994] > 0.07
Intra Native 0.970 [0.926–0.988] 0.978 [0.945–0.991] 0.984 [0.960–0.994] > 0.17
Post 0.991 [0.977–0.996] 0.990 [0.975–0.996] 0.991 [0.978–0.997] > 0.60
*One-way ANOVA on log of absolute difference, Significance level p < 0.05
**2-sided F-Statistics with Bonferroni correction, minimal p-value of three pair-wise tests is listed, Significance level p < 0.017
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Fig. 4 Pie charts showing the distribution and average of the quality (top row) and artifact (bottom row) scoring across all T1-maps and across
both readers. Eighty-one percent of all images were scored with at least “good” image quality, with MOLLI having the highest average score and
the lowest artifact scoring. SAPPHIRE shows higher average quality and similar artifact scores compared with SASHA
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the T1-time to the choice of scan parameters. A
two-parameter fit for SASHA T1-mapping was recently
proposed [10] and initial results on an extension using a
variable flip-angle scheme for the bSSFP imaging read-
out to minimize the loss in accuracy were presented
[25]. Two parameter fitting has also been used for SAP-
PHIRE post-contrast T1-mapping [6]. However, imper-
fect inversion efficiency might impair the accuracy of
SAPPHIRE, when using a two-parameter fit for native
T1-mapping. The use of a predetermined correction
factor for incomplete inversion, as previously proposed
[17], might be warranted for this application.
The reported reference ECV values for MOLLI (~0.26)
and SR T1-mapping (~0.21) obtained in this study are in
good agreement with previous literature. For MOLLI,
ECV-values between 0.25 and 0.27 have been reported at
1.5T [9, 15, 26] and between 0.26 and 0.28 at 3T [26–29].
Furthermore, the slight increase in ECV-values between
the two post-contrast time points has been previously
observed with MOLLI at 3T [29], and the ECV deviation
between the two time points is in agreement with previous
reports (0.258–0.272 for times between 10 and 25 min
[28]. Close agreement of SAPPHIRE ECV-values are ob-
tained with a previous study at 1.5T (ECV: 0.20 [9]).
SASHA ECV-values were reported as 0.18 [9], 0.21 [30]
and 0.22 [31, 32] in healthy subjects at 1.5T. The close
agreement of these values with our results, as well as with
ECV-values obtained with SR T1-mapping in an animal
study at 3T (AIR: 0.20–0.21 [33]) proves high cross field-
strength consistency for SR based ECV-measures.
Despite the higher precision of MOLLI compared to SR
T1-mapping, previous studies did not report significant
differences in the scan-rescan reproducibility [9, 26]. To
add on this, our results show no significant difference in
the inter- or intra-observer variability between the
methods either. All three methods showed consistency
with ICCs > 0.90, which is considered excellent for diag-
nostic tools [34]. The values of observer variability charac-
teristics obtained in this study are well in line with
previous reports [27, 35–38]. However, some studies from
specialized centers achieved consistently higher inter- and
intra-observer variability, with ICCs > 0.99 [27, 29, 39].
This difference might be explained by the limited clinical
experience of our readers. Therefore, extensive observer
training and an extensive common learning phase for both
readers seems to be required to achieve optimal reprodu-
cibility results in T1-mapping.
Imaging at 3T using bSSFP has considerable chal-
lenges compared with 1.5T. Off-resonance artifacts are
commonly induced by magnetic susceptibilities at tissue
interfaces, e.g. epicardium-lung interface. In this study,
frequency scouts were used to minimize off-resonance
artifacts. However, careful volumetric shimming is still
essential at 3T to ensure robust image quality. Also, the
rapid imaging readout reaches specific absorption rate
(SAR) limitations at 3T. As SR T1-mapping methods
were shown to be independent of the imaging flip-angle
[12], improved imaging SNR could potentially be
achieved using optimized excitation pulses with higher
flip-angles and low SAR, for the trade-off against
suboptimal slice profiles.
Non-rigid motion correction algorithms, as used in
this study, are dependent on strong contrast within the
area of interest [40]. Hence, MoCo was more effective
for MOLLI than for the SR methods. Tailored motion
correction algorithms might be required if a further re-
duction of residual motion in the SR imaging series is
necessary.
This study has several limitations. Due to the lack of
feasible methods for the assessment of “true” T1-times
in the myocardium, no direct evidence of the in-vivo ac-
curacy of SR methods can be given. Instead, phantom
accuracy was used as an indicator of in-vivo accuracy.
Evaluation of the sequence characteristics was restricted
to accuracy and precision, specifically no inter- or intra-
session reproducibility was considered in this study. A
tightly controlled cohort of young healthy volunteers
was recruited for the study, in order to obtain reprodu-
cible reference values of the healthy myocardium that
are not affected by potential age-related fibrosis in the
muscle. As the T1-time of the myocardium is known to
be age and sex dependent [41], cohorts that are age/sex
matched to the particular patient population are to be
assessed if more specific T1-reference values with re-
duced intra-cohort variability are required.
Conclusions
Saturation-recovery at 3T was shown to provide accurate
and robust T1-map quality at a field-strength of 3T. In-
vivo comparison to MOLLI showed decreased subjective
image quality scores, a slight loss in precision, but com-
parable inter-subject, inter-, and intra-observer variability.
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